Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Pantoprazole Sodium Patent Expiration

Pantoprazole Sodium was first introduced by Wyeth Pharmaceuticals Llc in its drug Protonix on Feb 2, 2000. Other drugs containing Pantoprazole Sodium are Pantoprazole Sodium, Pantoprazole Sodium In 0.9% Sodium Chloride, Protonix Iv. 41 different companies have introduced drugs containing Pantoprazole Sodium.


Pantoprazole Sodium Patents

Given below is the list of patents protecting Pantoprazole Sodium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Protonix US7544370

(Pediatric)

 Pantoprazole multiparticulate formulations Dec 07, 2026 Wyeth Pharms
Protonix US7544370 Pantoprazole multiparticulate formulations Jun 07, 2026 Wyeth Pharms
Protonix US7550153

(Pediatric)

 Pantoprazole multiparticulate formulations Mar 30, 2025

(Expired)

 Wyeth Pharms
Protonix US7553498

(Pediatric)

 Pantoprazole multiparticulate formulations Mar 30, 2025

(Expired)

 Wyeth Pharms
Protonix US7838027

(Pediatric)

 Pantoprazole multiparticulate formulations Mar 30, 2025

(Expired)

 Wyeth Pharms
Protonix US7550153 Pantoprazole multiparticulate formulations Sep 30, 2024

(Expired)

 Wyeth Pharms
Protonix US7553498 Pantoprazole multiparticulate formulations Sep 30, 2024

(Expired)

 Wyeth Pharms
Protonix US7838027 Pantoprazole multiparticulate formulations Sep 30, 2024

(Expired)

 Wyeth Pharms
Protonix Iv US6780881

(Pediatric)

 Freeze-dried pantoprazole preparation and pantoprazole injection May 17, 2022

(Expired)

 Wyeth Pharms
Protonix Iv US7351723

(Pediatric)

 Freeze-dried pantoprazole preparation and pantoprazole injection May 17, 2022

(Expired)

 Wyeth Pharms
Protonix Iv US8754108

(Pediatric)

 Freeze-dried pantoprazole preparation and pantoprazole injection May 17, 2022

(Expired)

 Wyeth Pharms
Protonix Iv US6780881 Freeze-dried pantoprazole preparation and pantoprazole injection Nov 17, 2021

(Expired)

 Wyeth Pharms
Protonix Iv US7351723 Freeze-dried pantoprazole preparation and pantoprazole injection Nov 17, 2021

(Expired)

 Wyeth Pharms
Protonix Iv US8754108 Freeze-dried pantoprazole preparation and pantoprazole injection Nov 17, 2021

(Expired)

 Wyeth Pharms
Protonix US5997903

(Pediatric)

 Oral-administration forms of a medicament containing pantoprazol Jun 07, 2017

(Expired)

 Wyeth Pharms
Protonix US5997903 Oral-administration forms of a medicament containing pantoprazol Dec 07, 2016

(Expired)

 Wyeth Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Pantoprazole Sodium's patents.

Given below is the list recent legal activities going on the following patents of Pantoprazole Sodium.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 12 Apr, 2022 US7838027
Payment of Maintenance Fee, 8th Year, Large Entity 01 Dec, 2021 US8754108
Payment of Maintenance Fee, 12th Year, Large Entity 28 Sep, 2020 US7550153
Payment of Maintenance Fee, 12th Year, Large Entity 28 Sep, 2020 US7544370
Payment of Maintenance Fee, 12th Year, Large Entity 28 Sep, 2020 US7553498
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2019 US7351723
Payment of Maintenance Fee, 8th Year, Large Entity 13 Apr, 2018 US7838027
Payment of Maintenance Fee, 4th Year, Large Entity 30 Nov, 2017 US8754108
Email Notification
Critical
 01 Jul, 2016 US7550153
Email Notification
Critical
 01 Jul, 2016 US7553498


Pantoprazole Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Pantoprazole Sodium Generic API Manufacturers

Several generic applications have been filed for Pantoprazole Sodium. The first generic version for Pantoprazole Sodium was by Teva Pharmaceuticals Usa Inc and was approved on Aug 2, 2007. And the latest generic version is by Deva Holding As and was approved on May 16, 2025.

Given below is the list of companies who have filed for Pantoprazole Sodium generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Feb 7, 2011
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Feb 7, 2011


Manufacturing Plant Locations
New

Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.

Country City Firm Name
United States
Totowa Actavis Totowa LLC
Little Falls Actavis Totowa LLC





2. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Feb 9, 2023


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP Mar 31, 2025


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals, Ltd
Vadodara Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)





4. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 26, 2016
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 26, 2016





5. ANNORA PHARMA

Annora Pharma Private Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Annora Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Oct 27, 2023


Manufacturing Plant Locations
New

Annora Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Annora Pharma as present at those locations.

Country City Firm Name
India
Hyderabad Annora Pharma Private Limited





6. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP May 18, 2022


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





7. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Sep 28, 2012
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Mar 31, 2025


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





8. BE PHARMS

Be Pharmaceuticals Ag has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Be Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP May 18, 2022





9. CIPLA

Cipla Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Mar 31, 2025


Manufacturing Plant Locations
New

Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.

Country City Firm Name
India
Pithampur, District Dhar Cipla Limited
Bangalore Cipla Ltd.
Raigad Cipla Limited
Kurkumbh Village, Dist. Pune Cipla, Ltd.
Vasco Da Gama Cipla Limited
Mumbai Cipla Limited
Bengaluru Cipla Limited





10. DEVA HOLDING AS

Deva Holding As has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Deva Holding As.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP May 16, 2025





11. DEXCEL

Dexcel Pharma Technologies Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Dexcel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Jun 16, 2023


Manufacturing Plant Locations
New

Dexcel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Dexcel as present at those locations.

Country City Firm Name
Israel
Or Akiva Dexcel Pharma Ltd.
Yokne'Am Ilit Dexcel Pharma Technologies - Yokneam Factory





12. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011





13. EPIC PHARMA LLC

Epic Pharma Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP Nov 8, 2012





14. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP Mar 30, 2016


Manufacturing Plant Locations
New

Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.

Country City Firm Name
India
Pashamylaram Eugia Pharma Specialities Limited
Medchal-Malkajgiri District EUGIA Pharma Specialities Limited
Riico Industrial Area EUGIA Pharma Specialities Limited





15. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

powder Prescription INTRAVENOUS AP Aug 1, 2024


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA, LLC
Melrose Park Fresenius Kabi USA LLC
Lake Zurich Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Grand Island Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Bensenville Fresenius Kabi USA LLC (FK USA)





16. GLAND

Gland Pharma Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Gland.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP May 18, 2022


Manufacturing Plant Locations
New

Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.

Country City Firm Name
India
Hyderabad Gland Pharma Limited
Sriperumbudur Gland Chemical Private Limited
Hyderabad Gland Pharma Limited, Units I+II Pashamylaram Site
Parawada, Visakhapatnam Gland Pharma Limited
Malur Gland Chemicals Pvt Ltd.
Aurangabad Gland Chemical Private Limited
Visakhapatnam Gland Pharma Limited





17. GRANULES

Granules India Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Dec 11, 2023
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Dec 11, 2023


Manufacturing Plant Locations
New

Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.

Country City Firm Name
United States
Chantilly Granules Pharmaceuticals Inc.
Manassas Granules Consumer Health Inc.
India
Visakhapatnam Granules India Limited
Parawada Mandal Granules India Limited
Sangareddy District Granules India Limited
Medchal-Malkhajgiri District Granules India Limited
Secunderabad Granules India Limited





18. GRAVITI PHARMS

Graviti Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Graviti Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 16, 2025
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 16, 2025





19. HANGZHOU ZHONGMEI

Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Hangzhou Zhongmei.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP Aug 30, 2021


Manufacturing Plant Locations
New

Hangzhou Zhongmei's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hangzhou Zhongmei as present at those locations.

Country City Firm Name
China
Hangzhou Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
Hangzhou Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd





20. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Sep 10, 2014
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Sep 10, 2014





21. INGENUS PHARMS LLC

Ingenus Pharmaceuticals Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Ingenus Pharms Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Discontinued ORAL N/A Mar 1, 2019





22. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 30, 2011
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 30, 2011


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





23. KNACK

Knack Pharmaceuticals Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Knack.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP May 19, 2022





24. L PERRIGO CO

L Perrigo Co has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by L Perrigo Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A May 7, 2014





25. LANNETT CO INC

Lannett Co Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 20, 2011
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 20, 2011





26. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Discontinued ORAL N/A Feb 16, 2012
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Feb 16, 2012





27. MANKIND PHARMA

Mankind Pharma Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Mankind Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jul 26, 2022
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Apr 25, 2024


Manufacturing Plant Locations
New

Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.

Country City Firm Name
India
Imt Manesar Mankind Pharma Limited
Paonta Sahib Mankind Pharma Limited





28. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Prescription INTRAVENOUS AP Aug 29, 2022





29. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011





30. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Discontinued INTRAVENOUS N/A May 4, 2018





31. ORBION PHARMS

Orbion Pharmaceuticals Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Orbion Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Dec 2, 2014
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Dec 2, 2014





32. RUBICON

Rubicon Research Private Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB May 2, 2012
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB May 2, 2012


Manufacturing Plant Locations
New

Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.

Country City Firm Name
United States
Indianapolis Rubicon Foods LLC
Geismar Rubicon, LLC
Canada
Concord Rubicon Research Canada Limited
India
Ambarnath Rubicon Research Private Limited





33. SANDOZ

Sandoz Inc has filed for 1 generic for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE/VIAL

injectable Discontinued INTRAVENOUS N/A Jul 14, 2015


Manufacturing Plant Locations
New

Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.

Country City Firm Name
Austria
Langkampfen Sandoz GmbH
Kundl Sandoz GmbH
United States
Princeton Sandoz Inc
East Hanover Sandoz Incorporated
Spain
Les Franqueses Del Valles Sandoz Industrial Products S.A.
Palafolls Sandoz Industrial Products, S.A.
India
Navi Mumbai Sandoz Private Limited





34. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

for suspension, delayed release Prescription ORAL AB Jun 30, 2020
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Sep 10, 2007
EQ 40MG BASE/VIAL

injectable Discontinued INTRAVENOUS N/A Aug 19, 2019


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
Lexington Sun Pharmaceutical Industries Inc
India
New Delhi Sun Pharmaceutical Industries Limited
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Mohali Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Vadodara Sun Pharmaceutical Industries Ltd
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.
Halol Sun Pharmaceutical Industries Ltd.
Punjab Sun Pharmaceutical Industries, Inc.
Ahmednagar Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Vadodara Sun Pharmaceutical Industries Ltd.





35. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A May 2, 2012
EQ 40MG BASE

tablet, delayed release Discontinued ORAL N/A May 2, 2012





36. TEVA

Teva Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 2, 2007
EQ 40MG BASE

tablet, delayed release Discontinued ORAL N/A Aug 2, 2007


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Fort Dodge TEVA Animal Health Inc
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Markham Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





37. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011





38. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 2 different strengths of generic version for Pantoprazole Sodium. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 40MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011
EQ 20MG BASE

tablet, delayed release Prescription ORAL AB Jan 19, 2011